Zobrazeno 1 - 10
of 2 307
pro vyhledávání: '"ERADICATION THERAPY"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 5079-5086 (2024)
Dan Ma,1,* Yunhui Fang,2,* ZiWei Wang,1 Mosang Yu,1 Xin Xin Zhou1 1Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, People’s Republic of China; 2State Key Laboratory for D
Externí odkaz:
https://doaj.org/article/d27ef763a38a4f31aa7e2125545cae12
Publikováno v:
Acta Medica Bulgarica, Vol 51, Iss s2, Pp 148-152 (2024)
Recurrent aphthous stomatitis (RAS) is one of the most frequently encountered oral mucosal lesions. The RAS is characterized by recurrent painful ulcers, which can be either single or multiple. The prevalence rate of RAS ranges from 5 to 60% among th
Externí odkaz:
https://doaj.org/article/11443284bd314edab96c4a9ca9e823e8
Autor:
Eri Iwata, Mitsushige Sugimoto, Yoshika Akimoto, Mariko Hamada, Ryota Niikura, Naoyoshi Nagata, Kyosuke Yanagisawa, Takao Itoi, Takashi Kawai
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Helicobacter pylori eradication therapy reduces the risk of gastric cancer. However, it is unclear whether the severity of risk factors for gastric cancer such as atrophy and intestinal metaplasia are reduced after eradication in the long te
Externí odkaz:
https://doaj.org/article/451d499eb5854752910369c503a199bd
Publikováno v:
Клинический разбор в общей медицине, Vol 5, Iss 6, Pp 18-20 (2024)
The article presents a clinical case of the treatment of H. pylori infection and giardiasis in a 27-year-old female patient who had been suffering from spastic pain in the epigastrium, umbilical region, nausea and severity in the epigastrium after ea
Externí odkaz:
https://doaj.org/article/6df27b9367f74ebbb701577f730a4b53
Autor:
Sintayehu Fekadu, Seyife Kibru, Sisay Tesfaye, Tariku Egeno, Alemu Tamiso, Hizkel Engiso, Serawit Deyno
Publikováno v:
Gut Pathogens, Vol 16, Iss 1, Pp 1-10 (2024)
Abstract Background Dyspepsia is a common gastrointestinal illness sometimes associated with Helicobacter pylori (H. pylori) infection. Screening and eradicating the bacterium reduces the risk of infection-related complications. The aim of this study
Externí odkaz:
https://doaj.org/article/f4d9e27133c042bbaa3fab254fcbb0c9
Autor:
Т. L. Lapina, V. T. Ivashkin
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 33, Iss 6, Pp 81-87 (2024)
Аim: to present evidence justifying prescription of rebamipide during chronic gastritis.Key points. Experimental and clinical studies have demonstrated that rebamipide increases concentration of prostaglandins (prostaglandin E2 and prostacyclin) and
Externí odkaz:
https://doaj.org/article/78bd262750c3432794a594ddeec3a8d1
Improvement of dyspeptic symptoms after Helicobacter pylori eradication therapy in Japanese patients
Autor:
Eri Iwata, Mitsushige Sugimoto, Masaki Murata, Yuko Morino, Yoshika Akimoto, Mariko Hamada, Ryota Niikura, Naoyoshi Nagata, Takashi Kawai
Publikováno v:
JGH Open, Vol 7, Iss 12, Pp 855-862 (2023)
Abstract Background and Aim Helicobacter pylori eradication therapy effectively improves the abdominal symptoms and bowel habits of patients. Patients in whom dyspepsia is under control by 6 to 12 months after successful H. pylori eradication are def
Externí odkaz:
https://doaj.org/article/3abaa8cfd1e04ac1b149ac68a23b1c3c
Autor:
Yoshitaka Tokai, Yusuke Horiuchi, Noriko Yamamoto, Ken Namikawa, Shoichi Yoshimizu, Akiyoshi Ishiyama, Toshiyuki Yoshio, Toshiaki Hirasawa, Junko Fujisaki
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background The effect of Helicobacter pylori (H.pylori) eradication therapy on mixed-histological-type gastric cancer remains unclear. This study aimed to clarify the effect of H. pylori eradication therapy on mixed-histological-type early g
Externí odkaz:
https://doaj.org/article/5a4a81dd1c0c4b25bcb726677cab39df
Autor:
Sameh Mohamed Fakhry, Mohamed Abdel-Hameed Kandyl, Adel Ferig Hashish, Wafaa Kandeel, Ahmed Mostafa El-Shenawy, Hoda Samir El-Sayed, Mohamed Kamal Dewidar, Sameh Mohamed Badr, Nayra Shaker Mehanna
Publikováno v:
Egyptian Liver Journal, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Background H. Pylori is one of the commonest infectious diseases worldwide. In recent years, PPI-based triple therapy has been described to be losing its efficacy against H. pylori due to high rates of antibiotic resistance, antibiotics-asso
Externí odkaz:
https://doaj.org/article/69f03faba7c54e58933a3676b3b7b22e
Publikováno v:
Xin yixue, Vol 54, Iss 10, Pp 723-727 (2023)
Objective To explore the risk factors of re-positive after eradication therapy in patients with peptic ulcer（PU） complicated with Helicobacter pylori（Hp）infection， and to establish and verify a risk warning. Methods A total of 120 patients
Externí odkaz:
https://doaj.org/article/cada496f51bd4813823746323876f962